L & S Advisors Inc Pfizer Inc Transaction History

L & S Advisors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $4.55 Million - $5.39 Million	-97,736 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $2.08 Million - $2.57 Million	-45,365 Reduced 31.7%	97,736 $5.06 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $5.38 Million - $7.98 Million	130,286 Added 1016.67%	143,101 $8.45 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $502,988 - $646,132	12,815 New	12,815 $551,000
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $4.47 Million - $5.68 Million	-133,423 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $4.24 Million - $4.97 Million	133,423 New	133,423 $4.9 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $5.77 Million - $6.34 Million	-153,791 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $24,620 - $28,070	-640 Reduced 0.41%	153,791 $6.71 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $5.32 Million - $6.46 Million	154,431 New	154,431 $6.81 Million

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.